« back

Health Technology Assessment Programme: Commissioned calls (with potential Australian collaboration):(HTA)

  Wednesday, 28 Jul 2021 | Funding Deadline

The Health Technology Assessment (HTA) Programme funds research about the clinical and cost-effectiveness, and broader impact of healthcare treatments and tests, for those who plan, provide or receive care from NHS, and social care services.

The following commissioned calls come with the potential for Australian collaboration. The Australian National Health and Medical Research Council (NHMRC) will invest up to $3 million AUD to cover the Australian component of the research projects.

The HTA Programme is accepting stage 1 applications to their commissioned workstream for the following primary research topics:

 

• 21/18 Lumbar fusion for low back pain
• 21/19 Low energy contact X-ray brachytherapy (Papillon technique) or local excision for people with early stage rectal cancer where major surgery is not planned
• 21/20 Lipid-modifying therapy in children with familial hypercholesterolaemia
• 21/21 Percutaneous thermal ablation of benign thyroid nodules
• 21/22 Stretching programme for ambulant children with cerebral palsy
• 21/23 Strengthening programme for ambulant adolescents with cerebral palsy
• 21/25 Use of biologic drugs around the time of orthopaedic surgery
• 21/26 Microsuction compared with irrigation to remove earwax
• 21/27 Endoscopic versus open surgery for the treatment of cubital tunnel syndrome
• 21/28 Maintenance therapy for lichen sclerosus
• 21/29 Maintenance treatment for bipolar disorder
• 21/30 Non-conservative treatments for major low anterior resection syndrome

 

Deadline for proposals: 28th July 2021